Oral Oncology
Volume 39, Issue 3 , Pages 240-247 , April 2003

Effects of fibroblast growth inhibitor on proliferation and metastasis of oral squamous cell carcinoma

Received 9 July 2002 ,Accepted 30 July 2002.

References 

  1. Woolgar JA, Rogers S, West CR, Errington RD, Brown JS, Vaughan ED. Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol. 1999;35(3):257–265
  2. Yamamoto E, Kohama G, Sunakawa H, Iwai M, Hiratsuka H. Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer. 1983;51:2175–2180
  3. Yamamoto E, Kohama G, Hiratsuka H, Kumagai S. Role of preoperative chemotherapy for oral cancer from the viewpoint of mode of invasion. Asian J Oral Maxillofac Surg. 1994;6:113–121
  4. Suzawa H, Kikuchi S, Arai N, Koda A. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J Pharmacol. 1992;60:91–96
  5. Yashiro M, Chung YS, Sowa M. Tranilast (N- (3,4-dimethoxycinamoyl) anthranilic acid) down-regulates the growth-inhibition between gastric cancer cells and fibroblasts. Anticancer Res. 1997;17:895–900
  6. Isaji M, Miyata H, Ajisawa Y, Takehana Y, Yoshimura N. Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo. Br J Pharmacol. 1997;122:1061–1066
  7. Yatsunami J, Aoki S, Fukuno Y, Kikuchi Y, Kawashima M, Hayashi S. Antiangiogenic and antitumor effects of tranilast on mouse lung carcinoma cells. Int J Oncol. 2000;17:1151–1156
  8. Kawashiri S, Kumagai S, Kojima K, Harada H, Nakagawa K, Yamamoto E. Reproduction of occult metastasis of head and neck in nude mice. Clinical Experimental Metastasis. 1999;17:277–282
  9. Kawahara E, Okada Y, Nakanishi I, Iwata K, Kojima S, Kumagai S, et al. The expression of invasive behavior of differentiated squamous carcinoma cell line evaluated by an in vitro invasion model. Jpn J Cancer Res. 1993;84:409–418
  10. Kawashiri S, Kumagai S, Kojima K, Harada H, Yamamoto E. Development of a new invasion and metastasis model of human oral squamous cell carcinoma. Oral Oncol, Eur J Cancer. 1995;31B:216–221
  11. Kakihara K. Experimental study of the antitumor effect of an angiogenic agent on oral squamous cell carcinoma. J Juzen Med Soc. 1998;108:37–47 (in Japanese with English abstract)
  12. Yokoi T, Yamaguchi A, Odajima T, Furukawa K. Establishment and characterization of a human cell line derived from a squamous cell carcinoma of the tongue. Tumor Res. 1988;23:43–57
  13. Mosman T. Rapid colorimetric assay for cellular growth and survival. Application to proliferation and cytotoxicity assay. J Immunol Methods. 1983;65:55–63
  14. Sun J, Qian Y, Hamilton AD, Sebti SM. Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-ras mutation and p53 deletion. Cancer Res. 1995;55:4243–4247
  15. Tsuji T, Sasaki K, Kimura Y, Yamada K, Mori M, Shinozaki F. Measurement of proliferating cell nuclear antigen (PCNA) and its clinical application in oral cancers. Int J oral Maxillofac Surg. 1992;21:369–372
  16. Parums DV, Cordell JL, Micklem K, Heryst AR, Gatter KC, Mason DV. JC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol. 1990;43:752–757
  17. Yamamoto E, Sunakawa H, Kohama G. Clinical course of diffuse invasive carcinoma of the tongue excised after bleomycin treatment. J Maxillofac Surg. 1983;11:269–274
  18. Yamamoto E, Miyakawa A, Kohama G. Mode of invasion and lymph node metastasis in squamous cell carcinoma of oral cavity. Head Neck. 1984;6:939–947
  19. Murahashi K, Yashiro M, Inoue T, Nishimura S, Matsuoka T, Sawada T, et al. Tranilast and cisplatin as an experimental combination therapy for scirrhous gastric cancer. Int J Oncol. 1998;13:1235–1240
  20. Chiquet-Ehrismann R, Kalla P, Pearson AC. Participation of tenascin and transforming growth factor-βin reciprocal epithelial-mesenchymal interactions of MCF-7 cells and fibroblasts. Cancer Res. 1989;49:4322–4325
  21. Cronil I, Theodorescu D, Man S, Herlyn M, Jabrosic J, Kerbel RS. Fibroblast cell interaction with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci USA. 1991;88:6028–6032
  22. Ankrapp PD, Bevan RD. Insulin-like growth factor-I and human lung fibroblast- derived insulin-like growth factor-I stimulate the proliferation of human lung carcinoma cells in vitro. Cancer Res. 1993;53:3399–3404
  23. Gleave M, Hsieh TJ, Gao C, Eschenback CA, Chung LWK. Acceleration of human prostate cancer growth in vitro by factors produced by prostate and bone fibroblasts. Cancer Res. 1989;51:3753–3761
  24. Yashiro M, Chung YS, Sowa M. Role of orthotopic fibroblasts in the development of scirrhous gastric carcinoma. Jpn J Cancer Res. 1994;85:883–886
  25. Yashiro M, Chung YS, Kubo T, Hato F, Sowa M. Differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts. Br J Cancer. 1996;74:1094–1103
  26. Saiki I, Murata J, Yoneda J, Kobayashi H, Azuma I. Influence of fibroblasts on the invasion and migration of highly or weakly metastatic B16 melanoma cells. Int J cancer. 1994;56:867–873
  27. Gohji K, Nakajima M, Fabra A, Bucana DC, Eschenbach CA, Tsuruo T, et al. Regulation of gelatinase production in metastatic renal cell carcinoma by organ- specific fibroblasts. Jpn J Cancer Res. 1994;85:152–160
  28. Shemirani B, Crowe Head neck squamous cell carcinoma lines produce biologically active angiogenic factors DL. Oral Oncol. 2000;36(1):61–66
  29. Eatock MM, Schatzlein A, Kaye SB. Tumor vasculature as a target for anticancer therapy. Cancer Treat Rev. 1999;26:191–204
  30. Noguchi M, Kido Y, Kubota H, Kinjo H, Kohama G. Prognostic factors and relative risk for survival in N1-3 oral squamous cell carcinoma (a multivariate analysis using Cox's hazard model). Brit J Oral Maxillofacial Surg. 1999;37:433–437

PII: S1368-8375(02)00092-1

doi: 10.1016/S1368-8375(02)00092-1

Oral Oncology
Volume 39, Issue 3 , Pages 240-247 , April 2003